Notice names this product. Eugia US’s Lidocaine HCl Injection is named in FDA Class III recall D-0552-2026. Your particular item is not yet verified. Compare the identifiers and exclusions in the notice before deciding whether it applies. Agency-reported hazard: Labeling: Not Elsewhere Classified: The label wrap covers the barcode, making it hard to scan Identifying details: Lot, expiry: Lot 3LC26029A, exp Feb-2029; Lot 3LC26031A, exp Mar-2029. Units affected: 168,300 vials. Status: Ongoing.
This notice names a product; your particular item is not yet verified. Compare every applicable model, serial, lot, production-date or model-year boundary below.
Lidocaine HCl Injection, USP 2%, 40 mg/2 mL (20 mg/mL), 2 mL per Single-Dose Vial, Rx Only, Mfd. in India for: Eugia US LLC, E. Windsor, NJ 08520. NDC: 55150-164-02
Still to verify: match the label on your item with the full official notice, including any exclusions, tables and photos. Some identifiers appear only on the agency website and are absent from this data feed. A missing field does not mean all versions are affected.
If your lot or date falls outside a stated range, this notice has not established that your item is affected. This is not a finding about other recalls or product safety.
Labeling: Not Elsewhere Classified: The label wrap covers the barcode, making it hard to scan
Company / brand: Eugia US recalls
Affected product: Lidocaine HCl Injection recall status
Official ID D-0552-2026 · Official record ↗
Found something wrong or missing? Report a data error.
Compiled from connected official public-domain government data. Sources last checked October 22, 2026 at 6:00 PM UTC.